Atlas Trials

Poxel SA

14 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Poxel SA

RecordFirmDate
Study to Assess PXL770 in Subjects With Adrenomyeloneuropathy (AMN) Form of X-linked Adrenoleukodystrophy (X-ALD or ALD) (NCT05146284)Poxel SA2023-09-01
Study to Assess PXL065 in Subjects With Adrenomyeloneuropathy (AMN) Form of X-linked Adrenoleukodystrophy (X-ALD or ALD) (NCT05200104)Poxel SA2023-09-01
Study to Assess the Safety, Tolerability, and Pharmacokinetics of PXL770 in Healthy Subjects. (NCT05441904)Poxel SA2021-03-08
Study of PXL065 in Patients With Nonalcoholic Steatohepatitis (NASH) (NCT04321343)Poxel SA2020-09-01
A Study to Assess the Pharmacokinetics of PXL770 After 4 Weeks of Treatment in Subjects With NAFLD (NCT03950882)Poxel SA2019-08-01
A Study of the Efficacy and Safety of PXL770 Versus Placebo After 12 Weeks of Treatment in Patients With NAFLD (NCT03763877)Poxel SA2019-03-29
Pharmacokinetics and Metabolism of (14C)-Labelled PXL770 (NCT03886103)Poxel SA2019-02-06
Pharmacokinetics of Imeglimin in Hepatic Impaired Subjects (NCT03802786)Poxel SA2018-11-06
Bioequivalence of Imeglimin Tablet Formulations (NCT03646331)Poxel SA2018-09-03
Effect of Cimetidine on the PK of Imeglimin (NCT03618316)Poxel SA2018-06-19

Track Poxel SA automatically

Every clearance here is in the API, with alerts when new ones post.